ESMO 2022 curated collection – Lung cancer

Thursday, 17 Nov 2022


Watch again as experts present their highlights in lung cancer from this year’s ESMO meeting and discuss how they may impact practice:

  1. Game changers in lung cancer
  2. Translational lung cancer updates – feat. Charles Swanton’s study
  3. Targeted therapy in mNSCLC – feat. CodeBreak 200
  4. Adjuvant & neoadjuvant therapy in NSCLC – feat. ADAURA, INSIGHT-02, INCREASE
  5. Immunotherapy in mNSCLC – feat. IPSOS, DICIPLE, DIAL, EMPOWER- lung 1

Game changers in lung cancer

Translational lung cancer updates

Targeted therapy in mNSCLC

Adjuvant & neoadjuvant therapy in NSCLC

Immunotherapy in mNSCLC

These events were supported by unrestricted educational grants and created independently by the limbic in collaboration with the hosts and panels. All studies were selected by the panels and all views expressed are those of the hosts and panels only.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2023 the limbic